Home » Topics » BioWorld Science

BioWorld Science
RSS

Noxafil approved in Japan for deep fungal infections

Jan. 24, 2020

IGF1R inhibitors may find utility as head and neck squamous-cell carcinoma treatments

Jan. 24, 2020

Link between lipid metabolism, cancer stem cell death and anti-tumor immunity mediated by ARF1

Jan. 24, 2020

Ketamine and opioids

Jan. 24, 2020

Japanese approval of Dinagest for dysmenorrhea

Jan. 23, 2020

Altimmune demonstrates systemic antitumor activity with ALT-702 in preclinical study

Jan. 23, 2020

China's NMPA clears ASC-22 to begin trials for HBV in China

Jan. 23, 2020

Nubeqa approved in Japan for nonmetastatic castration-resistant prostate cancer

Jan. 23, 2020

DIRC3 acts as a tumor suppressor in melanoma

Jan. 23, 2020

FDA clears IND application for HEALEY ALS platform trial

Jan. 23, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...